Healthcare

This issue of Vital Signs, released on February 28, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences and Advanced Medical Technology.

This issue of Vital Signs, released on February 27, 2013, provides an insight in to the medical imaging market in the Middle East. It is a commentary on the annual Arab Health conference held in Dubai on Jan. 28-31, 2013, Additionally, a company spotlight is provided for NextGate. NextGate is a leading provider of Enterprise Master Patient Index (...

This research service focuses on the current status of the prostate cancer therapeutics pipeline candidates with a focus on segmentation, current Phase 1-3 candidates and detailed clinical trial timelines. Prostate cancer incidence and three big predictions are also included in this research service.

The marketed and development product landscape for diabetes therapeutics is becoming crowded with multiple products with little differentiation. However, there is still ample room for growth through the introduction of novel therapies that fill therapeutic gaps left by available products. Comprehensive information on market background and global ...

Burden of Disease or Conditions Decision Support Database provides information on exhaustive list of Measurements on Incidence, Prevalence and Mortality for different types of Communicable and Non Communicable Disease.

Dyslipidemia exists in many forms and is prevalent in developed regions. Although many patients with moderately elevated lipids are well served by available therapies, there is a significant patient population for whom these therapies are inappropriate or inadequate, thereby prompting development of innovative therapies to fill the gaps. This res...